Company intelligence / Profile preview

Igenomix

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Igenomix offers a comprehensive portfolio of reproductive genetic diagnostic services including preconception carrier screening, preimplantation genetic testing (PGT), and prenatal screening. The company’s tests are used to improve fertility outcomes and reduce the risk of implantation failure or miscarriage. It has published over 460 scientific papers and holds more than six patents in the field

Therapeutic areas: Women's Health
Modalities: Genetic testingMolecular diagnostics
Industry: Molecular Diagnostics

Partnerships

Collaborates with fertility clinics globally

Beyond the preview

Go deeper on Igenomix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Igenomix.

Explore the full profile